相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIV Reservoir Dynamics in the Face of Highly Active Antiretroviral Therapy
Cecilia T. Costiniuk et al.
AIDS PATIENT CARE AND STDS (2015)
HIV-1 Tat affects the programming and functionality of human CD8+ T cells by modulating the expression of T-box transcription factors
Fabio Sforza et al.
AIDS (2014)
Surface-bound Tat inhibits antigen-specific CD8+ T-cell activation in an integrin-dependent manner
Chiara Chiozzini et al.
AIDS (2014)
Emerging therapies for food allergy
Corinne A. Keet et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Eradicating HIV-1 infection: seeking to clear a persistent pathogen
Nancie M. Archin et al.
NATURE REVIEWS MICROBIOLOGY (2014)
A Real Time PCR Platform for the Simultaneous Quantification of Total and Extrachromosomal HIV DNA Forms in Blood of HIV-1 Infected Patients
Anna Casabianca et al.
PLOS ONE (2014)
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study
Stefania Bellino et al.
RETROVIROLOGY (2014)
HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality
Sergio Serrano-Villar et al.
PLOS PATHOGENS (2014)
Cna Menges in HIV vaccine research for treatment and prevention
Barbara Ensoli et al.
FRONTIERS IN IMMUNOLOGY (2014)
B-cell subset alterations and correlated factors in HIV-1 infection
Simone Pensieroso et al.
AIDS (2013)
Immune activation and HIV persistence: implications for curative approaches to HIV infection
Nichole R. Klatt et al.
IMMUNOLOGICAL REVIEWS (2013)
Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia
Norma Rallon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression
Sergio Serrano-Villar et al.
JOURNAL OF INFECTION (2013)
Novel Biopanning Strategy To Identify Epitopes Associated with Vaccine Protection
Barbara C. Bachler et al.
JOURNAL OF VIROLOGY (2013)
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
Christine Katlama et al.
LANCET (2013)
The HIV-1 Tat Protein Induces the Activation of CD8+ T Cells and Affects In Vivo the Magnitude and Kinetics of Antiviral Responses
Francesco Nicoli et al.
PLOS ONE (2013)
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat proteinj
Tory P. Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Impact of HIV Type 1 DNA Levels on Spontaneous Disease Progression: A Meta-Analysis
Chrissa G. Tsiara et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
Liang Shan et al.
IMMUNITY (2012)
HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies
Paolo Monini et al.
PLOS ONE (2012)
Novel Cell and Gene Therapies for HIV
James A. Hoxie et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Innate Immune Control of HIV
Mary Carrington et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The T-Cell Response to HIV
Bruce Walker et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Therapeutic vaccines against HIV infection
Felipe Garcia et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Broadly Cross-Neutralizing Antibodies in HIV-1 Patients with Undetectable Viremia
M. Medina-Ramirez et al.
JOURNAL OF VIROLOGY (2011)
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy
Alex Sigal et al.
NATURE (2011)
Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells
Fabienne Rayne et al.
EMBO JOURNAL (2010)
Generation of effector CD8+T cells and their conversion to memory T cells
Weiguo Cui et al.
IMMUNOLOGICAL REVIEWS (2010)
Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes
Enrico Brunetta et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Impact of Viral Dose and Major Histocompatibility Complex Class IB Haplotype on Viral Outcome in Mauritian Cynomolgus Monkeys Vaccinated with Tat upon Challenge with Simian/Human Immunodeficiency Virus SHIV89.6P
Aurelio Cafaro et al.
JOURNAL OF VIROLOGY (2010)
Antiretroviral therapy and management of HIV infection
Paul A. Volberding et al.
LANCET (2010)
Targeting early infection to prevent HIV-1 mucosal transmission
Ashley T. Haase
NATURE (2010)
Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART
Barbara Ensoli et al.
PLOS ONE (2010)
Incomplete Peripheral CD4+ Cell Count Restoration in HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment
Colleen F. Kelley et al.
CLINICAL INFECTIOUS DISEASES (2009)
Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384
Gregory K. Robbins et al.
CLINICAL INFECTIOUS DISEASES (2009)
Rapid Desensitization for Hypersensitivity Reactions to Medications
Mariana Castells
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2009)
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles
Filomena Nappi et al.
JOURNAL OF GENE MEDICINE (2009)
HIV-1 Tat Addresses Dendritic Cells to Induce a Predominant Th1-Type Adaptive Immune Response That Appears Prevalent in the Asymptomatic Stage of Infection
Emanuele Fanales-Belasio et al.
JOURNAL OF IMMUNOLOGY (2009)
Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses
Asier Saez-Cirion et al.
JOURNAL OF IMMUNOLOGY (2009)
Defective Human Immunodeficiency Virus-Specific CD8+ T-Cell Polyfunctionality, Proliferation, and Cytotoxicity Are Not Restored by Antiretroviral Therapy
Stephen A. Migueles et al.
JOURNAL OF VIROLOGY (2009)
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs
Christopher M. Coleman et al.
RETROVIROLOGY (2009)
Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up
Olimpia Longo et al.
VACCINE (2009)
The preventive phase I trial with the HIV-1 Tat-based vaccine
Barbara Ensoli et al.
VACCINE (2009)
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity
Steven G. Deeks et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
The therapeutic phase I trial of the recombinant native HIV-1 Tat protein
Barbara Ensoli et al.
AIDS (2008)
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimens
Emanuele Nicastri et al.
CURRENT HIV RESEARCH (2008)
Cellular Reservoirs of HIV-1 and their Role in Viral Persistence
Aikaterini Alexaki et al.
CURRENT HIV RESEARCH (2008)
Immune activation and inflammation in HIV-I infection: causes and consequences
V. Appay et al.
JOURNAL OF PATHOLOGY (2008)
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS
Riccardo Gavioli et al.
VACCINE (2008)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
Asier Saez-Cirion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages
Elena Chertova et al.
JOURNAL OF VIROLOGY (2006)
Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity
LS Weinberger et al.
CELL (2005)
The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency:: Findings in a cohort of HIV-1 seroconverters
G Rezza et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity
R Gavioli et al.
JOURNAL OF IMMUNOLOGY (2004)
Dose sparing with intradermal injection of influenza vaccine
RT Kenney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans
S Buttò et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
M Pope et al.
NATURE MEDICINE (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection
MW Richardson et al.
BIOMEDICINE & PHARMACOTHERAPY (2003)
Switching effective antiretroviral therapy: A review
H Drechsler et al.
CLINICAL INFECTIOUS DISEASES (2002)
Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load
LG Kostrikis et al.
JOURNAL OF VIROLOGY (2002)
Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses
E Fanales-Belasio et al.
JOURNAL OF IMMUNOLOGY (2002)
Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA
YT Wu et al.
SCIENCE (2001)
Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy
JP Casazza et al.
JOURNAL OF VIROLOGY (2001)
分享论文
